Male infertility remains an underexplored issue in healthcare, despite its prevalence being nearly equal to that of female infertility. A lack of understanding of male reproductive health, including how lifestyle and environmental factors impact sperm production, has left the causes of male infertility unclear. This knowledge gap also prevents healthcare systems from recognizing male infertility as a marker for other health conditions, limiting progress in medically assisted reproduction (MAR) technologies.
Current tests for diagnosing male infertility are limited. Diagnosis typically relies on family history, semen analysis, physical exams, and hormone profiles. However, categories such as azoospermia, asthenozoospermia, oligozoospermia, and teratozoospermia cover broad conditions that have multiple causes, further complicating accurate diagnosis. As a result, male infertility often goes untreated, and couples may mistakenly assign the treatment burden to the female partner during MAR treatments.
The Study
A new study, prompted by the Male Reproductive Health Initiative (MRHI), highlights the importance of understanding the root causes of male infertility. Researchers stress the role of genetics, epigenetics, and lifestyle factors in male fertility. They also emphasize that male infertility has broader health implications, as studies show infertile men face a higher disease burden compared to fertile men. Understanding these factors is critical, not only for fertility but to prevent the inheritance of genetic causes of infertility in children born through assisted reproduction.
The review, developed as a result of consultations with global experts, aims to clarify the current knowledge of male reproductive health and identify key research gaps. This document targets researchers, policymakers, and the public, with recommendations to improve understanding and address the most pressing questions in male infertility.
Key Findings
The researchers identified 13 key questions that need further exploration to improve male infertility diagnosis and treatment. One of the main concerns is the lack of clarity surrounding the global prevalence of male infertility. Estimating the true prevalence is difficult, as most data comes from infertility clinics or at-risk populations exposed to toxins.
Semen analysis, often the primary diagnostic tool, has limitations. While sperm quality is important, fertility is a couple’s shared responsibility, and many men with compromised sperm production can still conceive if their female partner is healthy. In many cases, male infertility only becomes apparent if the female partner also faces fertility challenges.
The study also addressed the limitations of current diagnostic techniques, pointing out that while several methods are used, the underlying causes of male infertility remain unclear. Additionally, the review emphasized the need for improved treatments for male infertility, including better options to address genetic, lifestyle, and environmental factors. The intergenerational impact of epigenetic factors on fertility was also discussed.
Other significant concerns covered in the review included the economic and health burdens of male infertility, the potential for gamete storage or restoration before medical treatments, and the long-term effects of compromised fertility on children, whether conceived naturally or through assisted reproduction.
Finally, the study called for better communication about male reproductive health to health professionals, policymakers, and the general public.
Conclusions
The review highlights the need for greater understanding of male infertility, focusing on its causes, diagnosis, and treatment. It calls for improved research into genetic and environmental factors and advocates for better communication about male reproductive health to stakeholders at all levels.
Related topics:
